G. Vaughan Hudson - Concepedia

Author

G. Vaughan Hudson

Also Known As

G Vaughan Hudson, G. V. Hudson, G. Vaughan Hudson, G.V. Hudson, G.Vaughan Hudson, Gemma Hudson, Gillian Vaughan Hudson, K. A. MacLennan

Publications

7.2K

Citations

H-Index

Concepts

All Affiliations

University College London North Middlesex Hospital Middlesex Hospital Mount Vernon Hospital Royal London Hospital

About

G. Vaughan Hudson is an author at University College London specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	31	3.3K
2	Health Sciences	8	8	1.4K
3	Public Health	4	4	145
4	Allergy	1	1	52
5	Biostatistics	1	1	14

G. Vaughan Hudson

Publications

6.8K

Citations

H-Index

Page 1

	Year	Citations
A Prognostic Score for Advanced Hodgkin's Disease Dirk Hasenclever, Volker Diehl, Jamés O. Armitage, New England Journal of Medicine	1998	1.7K
Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial David C. Linch, A. H. Goldstone, Annabel McMillan, The Lancet TransplantationMarrow TransplantationStem Cell TransplantationHematologyCell Replacement Therapy	1993	1K
Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial KM Ardeshna, Peter Smith, AJ Norton, The Lancet Lymphoid NeoplasiaLong-term EffectHealth PolicyMedicineSystemic Treatment	2003	538
Risk of Second Malignancy After Hodgkin’s Disease in a Collaborative British Cohort: The Relation to Age at Treatment Anthony J. Swerdlow, Julie Barber, G. Vaughan Hudson, Journal of Clinical Oncology	2000	475
Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study ME Hill, KA MacLennan, David Cunningham, Blood	1996	311
Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. Anthony J. Swerdlow, A. J. Douglas, G. Vaughan Hudson, BMJ	1992	244
REVIEW OF BRITISH NATIONAL LYMPHOMA INVESTIGATION STUDIES OF HODGKIN'S DISEASE AND DEVELOPMENT OF PROGNOSTIC INDEX J. L. Haybittle, M.J. Easterling, MR Bennett, The Lancet Lymphoid NeoplasiaMedicineImmunodeficienciesSurgical PathologyDiagnosis	1985	183
Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy B. Vaughan Hudson, G. Vaughan Hudson, KA MacLennan, British Journal of Cancer Lymphoid NeoplasiaSurgical OncologyLong-term Follow-upHealth SciencesRadiation Therapy	1994	175
Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease. A study of 1659 patients Kenneth MacLennan, Michael H. Bennett, Anna Tu, Cancer Nodular SclerosingDisease ProgressionImmunologyPathologyDermatology	1989	166
Lung Cancer After Hodgkin’s Disease: A Nested Case-Control Study of the Relation to Treatment Anthony J. Swerdlow, Minouk J. Schoemaker, R. Allerton, Journal of Clinical Oncology	2001	132

Page 1